Empowering Nurses: Communicating Potential Medication Misuse

Abstract

BACKGROUND

In nursing education and practice, we prepare nurses on topics such as patient care, pathophysiology, pharmacology, nursing leadership, and nursing competencies. Unfortunately, we may be missing the mark when it comes to integrating these topics and applying them to situations that arise in health care such as medication misuse. Nurses work intimately with patients and can recognize potential medication misuse by reviewing medication regimens and assessing necessity of PRN patient requests. In cases where nurses suspect misuse, they may or may not feel comfortable addressing these concerns with other members of the health care team.

AIMS

Study aims were to assess the baseline of whether nurses are comfortable with their level of skill to recognize potential patient medication misuse and to assess nurses’ comfortability with communicating these concerns with other nurses, providers, and patients.

METHODS

This survey study was designed to obtain practical information about nurses understanding of misused and diverted prescription medications and level of comfort with expressing concerns about the use of central nervous system depressants to inform education, practice, and research. Three-hundred and fifty nurses at one hospital were invited to participate in an anonymous REDCap survey.

RESULTS

Thirty-five percent of the surveyed nurses returned the survey. Responding nurses were more comfortable sharing their own knowledge and the need for more education on the topic than they were discussing interdisciplinary communication.

CONCLUSIONS

Empowering nurses to communicate this knowledge with others on the health care team has major public health implications to reduce the negative outcomes of misused medications.

Keywords

harm reduction nursing education drug misuse interpersonal relations

Get full access to this article

View all access options for this article.

References

Adams

(2017). Peplau’s contributions to psychiatric and nursing knowledge. Journal of Mental Health and Addiction Nursing, 1(1), 10-18.

American Nurses Association. (1991). Abuse of prescription drugs. https://www.nursingworld.org/practice-policy/nursing-excellence/official-position-statements/id/abuse-of-prescription-drugs/

Bogart

G. T.

(2011). Abuse of second-generation antipsychotics: What prescribers need to know. Current Psychiatry, 10(5), 77-79.

Buttram

M. E.

Kurtz

S. P.

Cicero

T. J.

Havens

J. R.

(2019). An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user. Drug and Alcohol Dependence, 204(July), 107554. https://doi.org/10.1016/j.drugalcdep.2019.107554

Cloesmeijer

M. E.

van den Oever

H. L. A.

Mathôt

R. A. A.

Zeeman

Kruisdijk-Gerritsen

Bles

C. M. A.

Nassikovker

de Meijer

A. R.

van Steveninck

F. L.

Arbouw

M. E. L.

(2020). Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics. British Journal of Clinical Pharmacology, 86(8), 1620-1631. https://doi.org/10.1111/bcp.14273

Comer

S. D.

Degroot

Edwards

R. R.

Haddox

J. D.

Vorsanger

Wasan

A. D.

Weiss

R. D.

Turk

D. C.

Robert

(2013). Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain, 154(11), 2287-2296. https://doi.org/10.1016/j.pain.2013.05.053

Evoy

K. E.

Morrison

M. D.

Saklad

S. R.

(2017). Abuse and misuse of pregabalin and gabapentin. Drugs, 77(4), 403-426. https://doi.org/10.1007/s40265-017-0700-x

Faulkner-Gurstein

(2017). The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social Science & Medicine, 180, 20-27. https://doi.org/10.1016/j.socscimed.2017.03.013

Fischer

Pang

Jones

(2020). The opioid mortality epidemic in North America: Do we understand the supply side dynamics of this unprecedented crisis? Substance Abuse Treatment, Prevention, and Policy, 15(1), 14. https://doi.org/10.1186/s13011-020-0256-8

10.

IQVIA Institute. (2019). Medicine use and spending in the U.S.: A review of 2018 and outlook to 2023 institute report. https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023

11.

Kim

(2019). The unsuspected threat of three opioid-like substitutes. Archives of Psychiatric Nursing, 33(4), 325-328. https://doi.org/10.1016/j.apnu.2019.01.003

12.

Kim

Lee

Kim

Jung

Chang

(2017). Quetiapine misuse and abuse: Is it an atypical paradigm of drug seeking behavior? Journal of Research in Pharmacy Practice, 6(1), 12-15. https://doi.org/10.4103/2279-042x.200987

13.

McLean Hospital. (2020). History and progress: Over 200 years of treatment, research, training, and education.

14.

Nadelmann

LaSalle

(2017). Two steps forward, one step back: Current harm reduction policy and politics in the United States. Harm Reduction Journal, 14(1), 1-7. https://doi.org/10.1186/s12954-017-0157-y

15.

National Institute on Drug Abuse. (2020). Evidence-based approaches to drug addiction treatment. https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/evidence-based-approaches-to-drug-addiction-treatment

16.

Patton

(2015). Qualitative research and evaluation methods. Sage.

17.

Peplau

H. E.

(1952). Interpersonal relations in nursing: A conceptual frame of reference for psychodynamic nursing. Putnam. https://doi.org/10.1097/00000446-195206000-00062

18.

Reierson Draugalis

Coons

Plaza

. (2017). Best practices for survey research reports: A synopsis for authors and reviewers. American Journal of Pharmaceutical Education, 72(1), 1-8.

19.

Rinker

Krieger

Neighbors

(2017). Social network factors and addictive behaviors among college students. Physiology & Behavior, 176(12), 139-148. https://doi.org/10.1016/j.physbeh.2017.03.040

20.

Schindler

E. A. D.

Tirado-Morales

D. J.

Kushon

(2013). Clonidine abuse in a methadone-maintained, clonazepam-abusing patient. Journal of Addiction Medicine, 7(3), 218-219. https://doi.org/10.1097/adm.0b013e31828ab8d4

21.

Schlosser

Harris

(2020). Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic. International Journal of Drug Policy, 83, 102896. https://doi.org/10.1016/j.drugpo.2020.102896

22.

Seale

J. P.

Dittmer

Sigman

E. J.

Clemons

Johnson

J. A.

(2014). Combined abuse of clonidine and amitriptyline in a patient on buprenorphine maintenance treatment. Journal of Addiction Medicine, 8(6), 476-478. https://doi.org/10.1097/ADM.0000000000000081

23.

Silva

Kelly

(2020). The escalation of the opioid epidemic. American Journal of Managing Care, 26(7), 202-204. https://doi.org/10.37765/ajmc.2020.43386

24.

Stein

M. D.

Kenney

S. R.

Anderson

B. J.

Conti

M. T.

Bailey

G. L.

(2020). Prescnon-prescribed gabapentin use among persons seeking inpatient opioid detoxification. Journal of Substance Abuse Treatment, 110, 37-41. https://doi.org/10.1016/j.jsat.2019.12.007

25.

Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

26.

United Nations Office on Drugs and Crime. (2011). The non-medical use of prescription drugs, policy direction issues. https://www.unodc.org/documents/drug-prevention-and-treatment/nonmedical-use-prescription-drugs.pdf

27.

U.S. Drug Enforcement Administration. (n.d.). Drug scheduling. https://www.dea.gov/drug-scheduling

28.

U.S. Food and Drug Administration. (2019). FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin and pregabalin. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin

29.

Volkow

N. D.

(2018). How science has revolutionized the understanding of drug addiction. Journal of Drug Addiction, Education and Eradication, 7(3), 1-32. https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/preface

30.

Wilens

Zulauf

Ryland

Carrellas

Catalina-Wellington

(2015). Prescription medication misuse among opioid dependent patients seeking inpatient detoxification. American Journal on Addictions, 24(2), 173-177. https://doi.org/10.1111/ajad.12159

31.

Wood

(2015). Drug diversion. Australian Prescriber, 38(5), 164-166. https://doi.org/10.18773/austprescr.2015.058

32.

Zhou

Bhattacharjee

Kwoh

C. K.

Tighe

P. J.

Malone

D. C.

Slack

Wilson

D. L.

Brown

J. D.

Lo-Ciganic

W.-H.

(2019). Trends, patient and prescriber characteristics in gabapentinoid use in a sample of United States ambulatory care visits from 2003 to 2016. Journal of Clinical Medicine, 9(1), 83. https://doi.org/10.3390/jcm9010083